The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 1 , Pages 257-259 , July 2010

Highlights from the 59th Annual Scientific Sessions of the American College of Cardiology, March 13 to 17, 2010, Atlanta, Georgia

  • Frederic S. Resnic, MD, MSc, FACC

      Affiliations

    • Corresponding Author InformationAddress for reprints: Frederic S. Resnic, MD, MSc, FACC, Division of Cardiology, Brigham and Women's Hospital, 75 Francis St, Tower 3B, Boston, MA 02115.
    • ,
  • Akshay Desai, MD, MPH, FACC

References 

  1. Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009;54:686–694
  2. Feldman T. The Endovascular Valve Edge-to-Edge Repair Study (EVEREST II). Presented at the 59th Scientific Sessions of the American College of Cardiology: Late Breaking Clinical Trials, March 14, 2010, Atlanta, Georgia.
  3. Goldman S. Radial artery grafts versus saphenous vein grafts in coronary artery bypass surgery: VA Cooperative Study (VA CABG) presented at the 59th Scientific Sessions of the American College of Cardiology: Late Breaking Clinical Trials, March 16, 2010, Atlanta, Georgia.
  4. Jones RH, Velazquez EJ, Michler RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360:1705–1717
  5. Michler RE. Influence of reduction of left ventricular volume on outcome after coronary artery bypass grafting with or without surgical ventricular reconstruction. Presented at the 59th Scientific Sessions of the American College of Cardiology: Late Breaking Clinical Trials, March 16, 2010, Atlanta, Georgia.
  6. Mega JL, Close SL, Wiviott SD, et al. Cytochrome P-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009;360:354–362
  7. Storey RF, Husted S, Harrington RA, et al. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes. J Am Coll Cardiol. 2007;50:1852–1856
  8. Wallentin L, Becker RC, Budahj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–1057
  9. Held C. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO trial. Presented at the 59th Scientific Sessions of the American College of Cardiology: Late Breaking Clinical Trials, March 16, 2010, Atlanta, Georgia.
  10. Park SJ. Five long-term safety and efficacy of stenting versus coronary-artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE Registry. Presented at the 59th Scientific Sessions of the American College of Cardiology: Late Breaking Clinical Trials, March 14, 2010, Atlanta, Georgia.
  11. Seung KB, Park DW, Kim YH, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med. 2008;358:1781–1792

PII: S0022-5223(10)00363-6

doi: 10.1016/j.jtcvs.2010.04.003

The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 1 , Pages 257-259 , July 2010

Article Tools